Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer

NCT02485548 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Cancer

Interventions

DRUG: Raltitrexed
DRUG: 5-fluorouracil
DRUG: Cisplatin
RADIATION: IMRT

Sponsor

Jiangsu Cancer Institute & Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]